These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33196419)

  • 41. [Role of videocapillaroscopy in early detection of transition from primary to secondary Raynaud's phenomenon in systemic sclerosis].
    Secchi ME; Sulli A; Grollero M; Pizzorni C; Parodi M; Paolino S; Seriolo B; Cutolo M
    Reumatismo; 2008; 60(2):102-7. PubMed ID: 18651053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postocclusive reactive hyperemia in hand-arm vibration syndrome.
    Stoyneva Z
    Int J Occup Med Environ Health; 2016; 29(4):659-66. PubMed ID: 27443761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile.
    Riccieri V; Spadaro A; Ceccarelli F; Scrivo R; Germano V; Valesini G
    Lupus; 2005; 14(7):521-5. PubMed ID: 16130507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.
    Khan F; Coffman JD
    Circulation; 1994 Mar; 89(3):1183-8. PubMed ID: 8124805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral Gangrene as the Initial Presentation of Systemic Lupus Erythematosus in Emergency Department.
    Alalawi ZM; Alkenany S; Almahroos F; Albloushi B
    Cureus; 2020 Jan; 12(1):e6667. PubMed ID: 31966953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Headache, Raynaud's syndrome and serotonin receptor agonists in systemic lupus erythematosus.
    Bernatsky S; Pineau CA; Lee JL; Clarke AE
    Lupus; 2006; 15(10):671-4. PubMed ID: 17120594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients.
    Callen JP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):278-88. PubMed ID: 3871800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doppler spectral waveform analysis of arteries of the hand in patients with Raynaud's phenomenon as compared with healthy subjects.
    Chikui T; Izumi M; Eguchi K; Kawabe Y; Nakamura T
    AJR Am J Roentgenol; 1999 Jun; 172(6):1605-9. PubMed ID: 10350298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cutaneous vasoconstrictor response to venous stasis is normal in subjects with primary Raynaud's disease.
    Edwards CM; Marshall JM; Pugh M
    Clin Auton Res; 1999 Oct; 9(5):255-62. PubMed ID: 10580877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hand function and performance of daily activities in systemic lupus erythematosus: a clinical study.
    Malcus Johnsson P; Sandqvist G; Nilsson JÅ; Bengtsson AA; Sturfelt G; Nived O
    Lupus; 2015 Jul; 24(8):827-34. PubMed ID: 25542902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nailfold microvascular changes in patients with systemic lupus erythematosus and their associative factors.
    Fatemi A; Erlandsson BE; Emrani Z; Etehadtavakol M; Smiley A; Karbalaie A
    Microvasc Res; 2019 Nov; 126():103910. PubMed ID: 31408627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of connective tissue disorder-related acral syndromes using UVA-1 phototherapy. An open study of 11 cases].
    Comte C; Bessis D; Picot E; Peyron JL; Guillot B; Dereure O
    Ann Dermatol Venereol; 2009 Apr; 136(4):323-9. PubMed ID: 19361698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
    Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
    J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases.
    Ohtsuka T
    Int J Dermatol; 1999 Oct; 38(10):757-64. PubMed ID: 10561047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated homocysteine levels in patients with Raynaud's phenomenon secondary to systemic lupus erythematosus.
    Cheng TT; Chiu CK
    Clin Rheumatol; 2002 Jun; 21(3):251-4. PubMed ID: 12111632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment.
    Lee P; Leung FY; Alderdice C; Armstrong SK
    J Rheumatol; 1983 Dec; 10(6):930-8. PubMed ID: 6663597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.